December 18, 2023
Heart monitoring device manufacturer
BioTelemetry Inc. and its subsidiary,
LifeWatch Services Inc., have agreed to pay more than
$14.7 million for causing false claims to be submitted to federal healthcare programs. The claims were brought in two separate
qui tam suits, one by an employee of one of LifeWatch’s customers, Michael Pelletier, and the other by SFP I LLC. The whistleblowers alleged that the companies knew the design of their enrollment portal would steer clinical staff into enrolling patients in telemetry, which is reimbursed at a higher rate, rather than holter monitoring and event monitoring, which is reimbursed at a lower rate.
DOJ